Notch signaling activation is critical to the development of neuropathic pain

BackgroundNerve injury-induced neuropathic pain is a major health problem worldwide. Notch signaling is a highly conserved pathway in evolution, which has an important role in synaptic plasticity and inflammation in central nervous system. The present study was designed to investigate the potential role of notch signaling in the development of neuropathic pain.MethodsThe neuropathic pain was induced by spared nerve injury (SNI) in rats. The activation of notch signaling in the lumbar spinal dorsal horn was measured. DAPT, an inhibitor of notch signaling, was intrathecally (i.t.) administered before SNI or after appearance of pain sensitivity. Moreover, Jagged-1 (JAG-1) peptide, a ligand of notch signaling, was i.t. administered to normal rats. The mechanical allodynia was assessed by von Frey test.ResultsHere, we found that DAPT administered 0.5 h before SNI operation could significantly prevent the decrease of mechanical paw withdrawal threshold (PWT) for more than 4 weeks (P < 0.05 vs. SNI group). DAPT administered after appearance of pain sensitivity could also significantly reverse the decrease of mechanical PWT in a dose-dependent manner (P < 0.05). In addition, administration of Jagged-1 (JAG-1) peptide significantly decreased the mechanical PWT of normal rats in a dose-dependent manner (P < 0.05).ConclusionsTherefore, notch signaling activation might contribute to the development of neuropathic pain. This study might provide a new therapeutic target for neuropathic pain.

[1]  M. Mattson,et al.  Gamma secretase–mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke , 2006, Nature Medicine.

[2]  M. Fortini,et al.  Notch signaling: the core pathway and its posttranslational regulation. , 2009, Developmental cell.

[3]  R. Coggeshall,et al.  Peripheral nerve injury triggers central sprouting of myelinated afferents , 1992, Nature.

[4]  E. Cisneros,et al.  Cell cycle control of Notch signaling and the functional regionalization of the neuroepithelium during vertebrate neurogenesis. , 2009, The International journal of developmental biology.

[5]  C. Woolf.  Evidence for a central component of post-injury pain hypersensitivity , 1983, Nature.

[6]  G. Gebhart,et al.  Chronic pain and medullary descending facilitation , 2002, Trends in Neurosciences.

[7]  W D Willis,et al.  Role of Neurotransmitters in Sensitization of Pain Responses , 2001, Annals of the New York Academy of Sciences.

[8]  Maria Fitzgerald,et al.  The development of nociceptive circuits , 2005, Nature Reviews Neuroscience.

[9]  T. Gridley.  Notch signaling in vascular development and physiology , 2007, Development.

[10]  Jörn Lötsch,et al.  GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence , 2006, Nature Medicine.

[11]  E. Bongarzone,et al.  Notch Signaling in Astrocytes and Neuroblasts of the Adult Subventricular Zone in Health and after Cortical Injury , 2006, Developmental Neuroscience.

[12]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[13]  K. Selmaj,et al.  Overcoming failure to repair demyelination in EAE: γ-secretase inhibition of Notch signaling , 2008, Journal of the Neurological Sciences.

[14]  M. Ravalji.  Pathobiology of neuropathic pain , 2015 .

[15]  Hiroshi Baba,et al.  Partial Peripheral Nerve Injury Promotes a Selective Loss of GABAergic Inhibition in the Superficial Dorsal Horn of the Spinal Cord , 2002, The Journal of Neuroscience.

[16]  A. Michelucci,et al.  Notch signaling modulates the activation of microglial cells , 2007, Glia.

[17]  K. Selmaj,et al.  Overcoming failure to repair demyelination in EAE: gamma-secretase inhibition of Notch signaling. , 2008, Journal of the neurological sciences.

[18]  Austin G Smith,et al.  Peripheral Demyelination and Neuropathic Pain Behavior in Periaxin-Deficient Mice , 2000, Neuron.

[19]  P. Rakic,et al.  Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. , 1999, Science.

[20]  C. Woolf,et al.  The neuropathic pain triad: neurons, immune cells and glia , 2007, Nature Neuroscience.

[21]  Tian-Li Wang,et al.  Notch signaling, gamma-secretase inhibitors, and cancer therapy. , 2007, Cancer research.

[22]  Angeliki Louvi,et al.  Notch signalling in vertebrate neural development , 2006, Nature Reviews Neuroscience.

[23]  Tianming Yuan,et al.  Notch signaling: Key role in intrauterine infection/inflammation, embryonic development, and white matter damage? , 2009, Journal of neuroscience research.

[24]  I. Shih,et al.  Notch Signaling, γ-Secretase Inhibitors, and Cancer Therapy: Figure 1. , 2007 .

[25]  Alcino J. Silva,et al.  Notch to remember , 2005, Trends in Neurosciences.

[26]  David J Anderson,et al.  Transient Notch Activation Initiates an Irreversible Switch from Neurogenesis to Gliogenesis by Neural Crest Stem Cells , 2000, Cell.

[27]  C. Woolf,et al.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.

[28]  G. Wasner,et al.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment , 2010, The Lancet Neurology.

[29]  Jianren Mao,et al.  Notch3 is necessary for neuronal differentiation and maturation in the adult spinal cord , 2014, Journal of cellular and molecular medicine.

[30]  F. Guillemot,et al.  Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity , 2009, Nature Neuroscience.

[31]  M. Goulding,et al.  Ascl1 and Gsh1/2 control inhibitory and excitatory cell fate in spinal sensory interneurons , 2006, Nature Neuroscience.

[32]  Ming-Gang Liu,et al.  Imbalance between excitatory and inhibitory amino acids at spinal level is associated with maintenance of persistent pain-related behaviors. , 2009, Pharmacological research.